Ivan Staikov

931 total citations
19 papers, 508 citations indexed

About

Ivan Staikov is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Hematology. According to data from OpenAlex, Ivan Staikov has authored 19 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 6 papers in Hematology. Recurrent topics in Ivan Staikov's work include Cerebrovascular and Carotid Artery Diseases (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ivan Staikov is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ivan Staikov collaborates with scholars based in Bulgaria, Switzerland and Germany. Ivan Staikov's co-authors include Fernando Dangond, Jerry S. Wolinsky, Xavier Montalbán, Martin S. Weber, Douglas L. Arnold, Karolina Piasecka‐Stryczynska, Emily C. Martin, Sana Syed, Heinrich P. Mattle and Luca Remonda and has published in prestigious journals such as New England Journal of Medicine, Neurology and Stroke.

In The Last Decade

Ivan Staikov

16 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Staikov Bulgaria 9 164 132 116 115 109 19 508
Jun Kikuchi Japan 13 59 0.4× 65 0.5× 88 0.8× 59 0.5× 151 1.4× 66 594
Carola Metzig Germany 10 324 2.0× 34 0.3× 121 1.0× 36 0.3× 84 0.8× 16 723
Ido Didi Fabian Israel 20 91 0.6× 109 0.8× 209 1.8× 111 1.0× 70 0.6× 84 1.2k
Shabina Sultan United Kingdom 10 140 0.9× 52 0.4× 84 0.7× 388 3.4× 157 1.4× 12 729
Winny Varikatt Australia 14 40 0.2× 92 0.7× 57 0.5× 75 0.7× 37 0.3× 44 404
Zhifeng Mao China 13 208 1.3× 38 0.3× 302 2.6× 48 0.4× 81 0.7× 25 533
Hidekachi Kurotaki Japan 14 68 0.4× 150 1.1× 195 1.7× 69 0.6× 18 0.2× 54 620
Eleonora Russo Italy 13 193 1.2× 87 0.7× 67 0.6× 19 0.2× 89 0.8× 28 555
S. Vagnani Italy 10 142 0.9× 53 0.4× 36 0.3× 65 0.6× 169 1.6× 13 554
K. Mariampillai France 14 211 1.3× 148 1.1× 103 0.9× 628 5.5× 160 1.5× 28 906

Countries citing papers authored by Ivan Staikov

Since Specialization
Citations

This map shows the geographic impact of Ivan Staikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Staikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Staikov more than expected).

Fields of papers citing papers by Ivan Staikov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Staikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Staikov. The network helps show where Ivan Staikov may publish in the future.

Co-authorship network of co-authors of Ivan Staikov

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Staikov. A scholar is included among the top collaborators of Ivan Staikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Staikov. Ivan Staikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vermersch, Patrick, Cristina Granziera, Yang Mao‐Draayer, et al.. (2024). Inhibition of CD40L with Frexalimab in Multiple Sclerosis. New England Journal of Medicine. 390(7). 589–600. 34 indexed citations
2.
Giovannoni, Gavin, Cristina Granziera, Yang Mao‐Draayer, et al.. (2024). 151. Safety and Efficacy of Frexalimab in the Treatment of Relapsing Multiple Sclerosis: 18-month Results from the Phase 2 Open-Label Extension. Multiple Sclerosis and Related Disorders. 92. 106112–106112. 1 indexed citations
3.
Montalbán, Xavier, Jerry S. Wolinsky, Douglas L. Arnold, et al.. (2022). Safety and Efficacy of Evobrutinib, a Bruton’s Tyrosine Kinase Inhibitor in Relapsing Multiple Sclerosis Over 2.5 Years of The Open-Label Extension to a Phase II Trial (P5-4.001). Neurology. 98(18_supplement). 3 indexed citations
4.
Montalbán, Xavier, Douglas L. Arnold, Martin S. Weber, et al.. (2021). Evobrutinib Efficacy is Maintained Over Two Years in an Open-label Phase II Study Extension in Patients with Relapsing Multiple Sclerosis (4124). Neurology. 96(15_supplement). 4 indexed citations
5.
Montalbán, Xavier, Douglas L. Arnold, Martin S. Weber, et al.. (2021). Safety of Evobrutinib in Patients With Relapsing Multiple Sclerosis is Maintained in a Long-term Open-label Extension of a Phase II Study (4131). Neurology. 96(15_supplement). 1 indexed citations
6.
Montalbán, Xavier, Douglas L. Arnold, Martin S. Weber, et al.. (2019). 056 Efficacy and safety of the Bruton’s tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing multiple sclerosis over 48 weeks: a randomized, placebo-controlled, phase 2 study. Journal of Neurology Neurosurgery & Psychiatry. 90(e7). A18.2–A19. 1 indexed citations
7.
8.
Montalbán, Xavier, Douglas L. Arnold, Martin S. Weber, et al.. (2019). Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis. New England Journal of Medicine. 380(25). 2406–2417. 238 indexed citations
9.
Waje‐Andreassen, Ulrike, Darius G. Nabavi, Stefan T. Engelter, et al.. (2018). European Stroke Organisation certification of stroke units and stroke centres. European Stroke Journal. 3(3). 220–226. 32 indexed citations
10.
Staikov, Ivan, et al.. (2016). Diagnostic value of color-coded duplex sonography in patients with ischemic stroke and congenital changes in the circle of Willis. Cor et Vasa. 58(6). e591–e599. 1 indexed citations
11.
Staikov, Ivan, et al.. (2015). Is herpes simplex a systemic disease?. Clinics in Dermatology. 33(5). 551–555. 2 indexed citations
12.
13.
Staikov, Ivan, et al.. (2013). Herpes zoster as a systemic disease. Clinics in Dermatology. 32(3). 424–429. 19 indexed citations
14.
Mey, Christian de, et al.. (2011). Bioequivalence of a Novel High-dose Oral Formulation of α-Dihydroergocryptine. Arzneimittelforschung. 56(3). 205–211.
15.
Schuepbach, Daniel, et al.. (2002). Temporal modulation of cerebral hemodynamics under prefrontal challenge in schizophrenia: a transcranial Doppler sonography study. Psychiatry Research Neuroimaging. 115(3). 155–170. 13 indexed citations
16.
Staikov, Ivan, Krassen Nedeltchev, Marcel Arnold, et al.. (2002). Duplex sonographic criteria for measuring carotid stenoses. Journal of Clinical Ultrasound. 30(5). 275–281. 36 indexed citations
17.
Staikov, Ivan, Marcel Arnold, Heinrich P. Mattle, et al.. (2000). Comparison of the ECST, CC, and NASCET grading methods and ultrasound for assessing carotid stenosis. Journal of Neurology. 247(9). 681–686. 80 indexed citations
18.
Staikov, Ivan, Daying Dai, Luca Remonda, et al.. (1999). The site of atheromatosis in the subclavian and vertebral arteries and its implication for angioplasty. Neuroradiology. 41(7). 537–542. 25 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Kikuchi Breakdown of academic impact, for papers by Carola Metzig Breakdown of academic impact, for papers by Ido Didi Fabian Breakdown of academic impact, for papers by Shabina Sultan Breakdown of academic impact, for papers by Winny Varikatt Breakdown of academic impact, for papers by Zhifeng Mao Breakdown of academic impact, for papers by Hidekachi Kurotaki Breakdown of academic impact, for papers by Eleonora Russo Breakdown of academic impact, for papers by S. Vagnani Breakdown of academic impact, for papers by K. Mariampillai
Rankless by CCL
2026